We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Actve is on a mission to change the way people connect with their favourite fitness creators. The company aspires to help creators earn an income and build a subscription business. Actve asserts that it caters to a variety of creator needs allowing them to live-stream their workouts, offer guided programs to customers, or use Actve's software to manage their clients. The company aims to become a contender in the digital fitness market that is projected to be worth £21 billion by 2022. It aims to launch its platform in September 2021. Actve will use the investment to develop its platform, hire key staff, build its user base, and work towards becoming an industry champion for fitness creators.
days to go: Expired investment: £165,627
Tiger and Butterfly is a high end children’s hair salon in central London aimed at children aged  2 - 14. They will offer services from the first cut to fantasy party hair and offer party packages.   The investment will be used to secure a premises and building works, stock and salon expenses. (EIS and SEIS Pending)
days to go: Expired investment: £33,140
Property Regions has been designed to give people the opportunity to invest in property in the UK. They will be focusing on East Anglia and East Midlands before eventually expanding out to other regions.
days to go: Expired investment: £102,510
Safari Deal is an online marketplace for global wildlife holidays and safaris. It connects travellers to 260+ qualified and reliable travel partners and 350+ wildlife adventures around 42 worldwide destinations, making it easy to research, compare, enquire and book the next adventure. Moreover, Safari Deal is growing at an impressive rate of 5 travel partners per week. From the proceeds, 40% will be used for digital marketing and PR, 10% will be used for platform development and management, 15% will be used for trade shows and international marketing, 25% will be used for staff, and 10% will be used for other running costs.

Pitch Rated

38%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £54,084
HouseStars is a comprehensive property maintenance application powered by AI, enabling convenient connections between property owners and various trade professionals, such as builders, plumbers, electricians, and gas engineers. With this app, property upkeep is simplified - you can choose a service provider based on their ratings, select a suitable date and time, engage in communication, leave reviews, and complete secure payments through an escrow system, all through your mobile device.
days to go: Expired investment: £162,203
LuxOlympus Mayfair are a Travel Agency who specialise in luxurious and exclusive holidays across the globe and are regulated and authorised by the TTA (Travel Trust Association). They are currently in discussions to build a presents in the UK, Greece, Italy, The Philippines, Monaco and China.  This year they aim to appoint representative in 3 main cities of India. (EIS Pending)
days to go: Expired investment: £121,910
Muzeums is a platform and mobile app that help visitors experience museums in a unique way, tailoring each visit to suit the personal interests and learning style. This is done using the mobile app to choose what you're interested in. 
days to go: Expired investment: £53,165
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph